SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 94 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,136 | -13.5% | 11,200 | 0.0% | 0.05% | -20.0% |
| Q2 2023 | $295,120 | +1.3% | 11,200 | 0.0% | 0.06% | -40.9% |
| Q4 2022 | $291,312 | -3.9% | 11,200 | 0.0% | 0.11% | +48.6% |
| Q3 2022 | $303,000 | +2.0% | 11,200 | 0.0% | 0.07% | +13.8% |
| Q2 2022 | $297,000 | -53.0% | 11,200 | 0.0% | 0.06% | -47.2% |
| Q1 2022 | $632,000 | -13.3% | 11,200 | 0.0% | 0.12% | -2.4% |
| Q4 2021 | $729,000 | +15.2% | 11,200 | 0.0% | 0.13% | +9.6% |
| Q3 2021 | $633,000 | -32.6% | 11,200 | 0.0% | 0.12% | -36.8% |
| Q2 2021 | $939,000 | +19.3% | 11,200 | 0.0% | 0.18% | +9.6% |
| Q1 2021 | $787,000 | +4.7% | 11,200 | 0.0% | 0.17% | -2.9% |
| Q4 2020 | $752,000 | +14.8% | 11,200 | 0.0% | 0.17% | -3.9% |
| Q3 2020 | $655,000 | – | 11,200 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |